The results show that both the AKTi and PI3Ki approaches led to significant sensitisation to TRAIL-induced apoptosis in all three prostate cancer cell lines, with the exception of the PI3Ki in PC3 cells (Figure 6a–c). The gene discussed is TNFSF10; the disease is Familial prostate cancer.